Compare · AJAX vs BIS
AJAX vs BIS
Side-by-side comparison of Ajax I (AJAX) and ProShares UltraShort Nasdaq Biotechnology (BIS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AJAX and BIS operate in n/a (n/a), so they compete in similar markets.
- AJAX carries a market cap of $753.1M.
Ajax I
Ajax I does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Ajax I was founded in 2020 and is based in New York, New York.
ProShares UltraShort Nasdaq Biotechnology
The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Latest AJAX
- SEC Form 25-NSE filed by Ajax I
- Cazoo to Begin Trading on NYSE Today Under the Symbol "CZOO"
- SEC Form SC 13G/A filed by Ajax I (Amendment)
- Ajax I filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events
- AJAX I Shareholders Approve Proposed Business Combination with Cazoo
- SEC Form 8-K filed by Ajax I
- SEC Form SC 13G filed by Ajax I
- SEC Form 10-Q filed by Ajax I
- Ajax I filed SEC Form 8-K: Other Events
- SEC Form DEFA14A filed by Ajax I